Wallstrom O, Stridsman C, Lindberg A, Nyberg F, Vanfleteren L
Chest. 2024; 166(6):1347-1359.
PMID: 39094732
PMC: 11638550.
DOI: 10.1016/j.chest.2024.07.150.
Ellingsen J, Janson C, Broms K, Hardstedt M, Hogman M, Lisspers K
J Clin Med. 2024; 13(13).
PMID: 38999421
PMC: 11242174.
DOI: 10.3390/jcm13133855.
Weitoft T, Ronnelid J, Lind A, de Vries C, Larsson A, Potempa B
Biomedicines. 2024; 12(5).
PMID: 38790926
PMC: 11118928.
DOI: 10.3390/biomedicines12050964.
Lindh A, Giezeman M, Theander K, Zakrisson A, Westerdahl E, Stridsman C
Int J Chron Obstruct Pulmon Dis. 2024; 19:1069-1077.
PMID: 38765768
PMC: 11102747.
DOI: 10.2147/COPD.S455080.
Bjornson M, Svensson A, He C, Skold M, Nyren S, Nygren-Bonnier M
Front Med (Lausanne). 2024; 11:1263511.
PMID: 38633311
PMC: 11021575.
DOI: 10.3389/fmed.2024.1263511.
Reference ranges for ambulatory heart rate measurements in a middle-aged population.
Persson A, Maneheim A, Economou Lundeberg J, Fedorowski A, Healey J, Sundstrom J
Heart. 2024; 110(12):831-837.
PMID: 38580434
PMC: 11137473.
DOI: 10.1136/heartjnl-2023-323681.
VE/VCO slope threshold optimization for preoperative evaluation in lung cancer surgery: identifying true high- and low-risk groups.
Kristenson K, Hylander J, Boros M, Hedman K
J Thorac Dis. 2024; 16(1):123-132.
PMID: 38410536
PMC: 10894426.
DOI: 10.21037/jtd-23-1292.
Occupational exposure and health surveys at metal additive manufacturing facilities.
Assenhoj M, Almstrand A, Kokelj S, Ljunggren S, Olin A, Karlsson H
Front Public Health. 2023; 11:1292420.
PMID: 38054074
PMC: 10694287.
DOI: 10.3389/fpubh.2023.1292420.
Applying the Rome Proposal on Exacerbations of Chronic Obstructive Pulmonary Disease: Does Comorbid Chronic Heart Failure Matter?.
Jacobson P, Lind L, Persson H
Int J Chron Obstruct Pulmon Dis. 2023; 18:2055-2064.
PMID: 37744733
PMC: 10517701.
DOI: 10.2147/COPD.S425592.
The Exacerbation of Chronic Obstructive Pulmonary Disease: Which Symptom is Most Important to Monitor?.
Jacobson P, Lind L, Persson H
Int J Chron Obstruct Pulmon Dis. 2023; 18:1533-1541.
PMID: 37492490
PMC: 10364823.
DOI: 10.2147/COPD.S417735.
Comparing severe COVID-19 outcomes of first and second/third waves: a prospective single-centre cohort study of health-related quality of life and pulmonary outcomes 6 months after infection.
Darlington P, Roel M, Cronhjort M, Hanna G, Hedman A, Joelsson-Alm E
BMJ Open. 2023; 13(7):e071394.
PMID: 37460259
PMC: 10357304.
DOI: 10.1136/bmjopen-2022-071394.
Clinical impact of routine sleep assessment by peripheral arterial tonometry in patients with COPD.
Hansson D, Andersson A, Vanfleteren L, Andelid K, Zou D, Hedner J
ERJ Open Res. 2023; 9(2).
PMID: 37101736
PMC: 10123515.
DOI: 10.1183/23120541.00458-2022.
Pulmonary function in a cohort of heart-healthy individuals from Northern Sweden-a comparison with discordant reference values.
Erelund S, Karp K, Arvidsson S, Johansson B, Sundstrom N, Wiklund U
BMC Pulm Med. 2023; 23(1):110.
PMID: 37020237
PMC: 10077603.
DOI: 10.1186/s12890-023-02403-w.
Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double-blind placebo-controlled clinical trial.
Ahlbeck L, Ahlberg E, Stuivers L, Bjorkander J, Nystrom U, Retsas P
Clin Exp Allergy. 2023; 53(8):809-820.
PMID: 37013723
PMC: 10947267.
DOI: 10.1111/cea.14307.
Gender Differences in Vitamin D Status and Determinants of Vitamin D Insufficiency in Patients with Chronic Obstructive Pulmonary Disease.
Minter M, Augustin H, van Odijk J, Vanfleteren L
Nutrients. 2023; 15(2).
PMID: 36678297
PMC: 9863414.
DOI: 10.3390/nu15020426.
Ventilatory efficiency in combination with peak oxygen uptake improves risk stratification in patients undergoing lobectomy.
Kristenson K, Hylander J, Boros M, Fyrenius A, Hedman K
JTCVS Open. 2022; 11:317-326.
PMID: 36172418
PMC: 9510865.
DOI: 10.1016/j.xjon.2022.06.018.
Alveolar Nitric Oxide in Chronic Obstructive Pulmonary Disease-A Two-Year Follow-Up.
Hogman M, Palm A, Sulku J, Stallberg B, Lisspers K, Broms K
Biomedicines. 2022; 10(9).
PMID: 36140313
PMC: 9496546.
DOI: 10.3390/biomedicines10092212.
Skeletal Myosteatosis is Associated with Systemic Inflammation and a Loss of Muscle Bioenergetics in Stable COPD.
Persson H, Sioutas A, Kentson M, Jacobson P, Lundberg P, Dahlqvist Leinhard O
J Inflamm Res. 2022; 15:4367-4384.
PMID: 35937916
PMC: 9355337.
DOI: 10.2147/JIR.S366204.
MAIT cell counts are associated with the risk of hospitalization in COPD.
Pincikova T, Parrot T, Hjelte L, Hogman M, Lisspers K, Stallberg B
Respir Res. 2022; 23(1):127.
PMID: 35585629
PMC: 9114286.
DOI: 10.1186/s12931-022-02045-2.
Exhaled nitric oxide in early rheumatoid arthritis and effects of methotrexate treatment.
Weitoft T, Lind A, Larsson A, Ronnelid J, Hogman M
Sci Rep. 2022; 12(1):6489.
PMID: 35444250
PMC: 9020158.
DOI: 10.1038/s41598-022-10334-5.